IP Library Granted Patent US 10,543,166
Granted Patent B2
US 10,543,166 · App. 12/825,215 · Granted Jan 28, 2020

Implantable drug delivery devices and methods of making the same

Inventors: Heejin Lee (Arlington, MA); Cheryl Larrivee-Elkins (Framingham, MA)
Assignee: TARIS Biomedical LLC
A61K9/0004A61K9/0034A61K9/2027A61K9/2031A61K9/2072A61K9/2095A61K31/165A61K31/167A61M31/002A61M31/007B65B1/16A61K9/2004A61K31/16A61M2202/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,543,166
App. No.
12/825,215
Granted
Jan 28, 2020
Kind
B2
Abstract

A drug delivery device is provided that includes a device body, a number of solid, compressed drug tablets, and a retention frame. The device body includes a drug reservoir lumen and a retention frame lumen. The number of solid, compressed drug tablets are positioned in the drug reservoir lumen, and the retention frame is positioned in the retention frame lumen. The drug tablets may be mini-tablets aligned in the drug reservoir lumen, with an interstice formed between any two adjacent drug tablets facilitating deformation of the device body. Systems and method are also provided for loading a drug delivery device. In one embodiment, the method includes positioning one or more solid drug units upstream of the drug delivery device; and driving the drug units into the drug delivery device with a flow of pressurized gas.

Claims (13)

1. An intravesical drug delivery device comprising:

a device body comprising a drug reservoir lumen and a retention frame lumen;

a plurality of solid drug units positioned in the drug reservoir lumen, each of the solid drug units being directly adjacent at least one other of the solid drug units; and

a retention frame positioned in the retention frame lumen,

wherein:

the solid drug units have a selectively imparted shape,

the solid drug units are cylindrical in shape, and

the solid drug units have opposed flat ends.

2. An intravesical drug delivery device comprising:

a device body comprising a drug reservoir lumen and a retention frame lumen;

at least two solid, elongated drug tablets positioned end-to-end in the drug reservoir lumen, the drug tablets having a length:width aspect ratio greater than 1:1; and

a retention frame positioned in the retention frame lumen,

wherein the solid drug tablets have flat end faces and a cylindrical side face.

Assignments (4)
MERGER Recorded May 6, 2026
From: TARIS BIOMEDICAL LLC
To: JANSSEN BIOTECH, INC.
Reel/Frame 074576/0807 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2014
From: LIRIS BIOMEDICAL, INC.
To: TARIS BIOMEDICAL LLC
Reel/Frame 033742/0538 →
CHANGE OF NAME Recorded Sep 15, 2014
From: TARIS BIOMEDICAL, INC.
To: LIRIS BIOMEDICAL, INC.
Reel/Frame 033744/0938 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2010
From: LEE, HEEJIN; LARRIVEE-ELKINS, CHERYL
To: TARIS BIOMEDICAL, INC.
Reel/Frame 024719/0756 →
Continuity (3)
Provisional Application 61220865 · Jun 26, 2009
Provisional Application 61241382 · Sep 10, 2009
Related Publication 20100331770A1 · Dec 30, 2010